Previous 10 | Next 10 |
home / stock / mvmdf / mvmdf news
OTC Markets Group Welcomes Mountain Valley MD Holdings Inc. to OTCQX PR Newswire NEW YORK , Aug. 27, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Mountain Val...
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA: 20MP) is pleased to announce that effective August 27, 2021, it will graduate from the OTCQB Venture Market ("OTCQB") and ...
Mountain Valley MD (OTCQB:MVMDF) appoints Dr. Azhar Rana as the company’s Chief Medical Officer. Dr. Rana brings to the company nearly two decades of life sciences experience in clinical development, pre and post launch medical affairs, regulatory and commercial str...
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce the appointment of Dr. Azhar Rana as the Company’s Chief Medical Officer (...
TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce the appointment of Gokul Kannan and Mark Gelnaw as advisors to the Company as well a...
TORONTO, July 07, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce the results of its recent controlled cold chain evaluation of the Company’s Q...
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to provide an update on the status of key initiatives: SOLUBILITY PATENT AND QUICKSOL...
Mountain Valley MD to Host Live, Virtual Town Hall Q&A Session with Company President & CEO, Dennis Hancock Mountain Valley MD to Host Live, Virtual Town Hall Q&A Session with Company President & CEO, Dennis Hancock Canada NewsWire TORONTO , May...
Mountain Valley MD Holdings ([[MVMDF]]) announces it has received its third-party Bio Safety Level 4 (“BSL-4”) lab study results from its recent COVID-19 viral clearance study conducted with its solubilized Ivermectin technology - Ivectosol.Study results showed that a singl...
TORONTO, May 18, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA:20MP) is pleased to announce it has received its third-party Bio Safety Level 4 (“BSL-4”) lab study results from it...
News, Short Squeeze, Breakout and More Instantly...
Mountain Valley MD Holdings Inc Company Name:
MVMDF Stock Symbol:
OTCMKTS Market:
Mountain Valley MD Holdings Inc Website:
Mountain Valley MD Holdings Inc (MVMDF) is expected to report for Q2 2022
Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that it has executed an Amended and Restated Supply and License Agreement (the “ Agreement ”) with Agrarius Corp. (&...
Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to provide a broad business update of its progress across its three core lines of business: Nutraceuticals - novel innovations through t...